Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway

Cisplatin is a commonly used drug for cancer treatment by crosslinking DNA, leading to apoptosis of cancer cells, resistance to cisplatin treatment often occurs, leading to relapse. Therefore, there is a need for the development of more effective treatment strategies that can overcome chemoresistanc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Oncol
Hlavní autoři: HUANG, HAIZHI, CHEN, ALLEN Y., YE, XINGQIAN, LI, BINGYUN, ROJANASAKUL, YON, RANKIN, GARY O., CHEN, YI CHARLIE
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2015
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4583523/
https://ncbi.nlm.nih.gov/pubmed/26315556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2015.3133
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky